Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.

Sector
MedTech
Region
London UK
Stage
Commercialisation
Fund Life Sciences EIS
Target Raise
£200k

Developing a platform designed to protect financial wellbeing for vulnerable customers.

The Investment Opportunity

Kalgera is developing a platform that utilises proprietary neuroscience and Artificial Intelligence technology, to help protect financial wellbeing for vulnerable customers who are more at risk of financial abuse and fraud – in particular, customers in the early stages of dementia. The Company is developing two core assets, the first being an App that securely connects bank accounts and alerts loved ones or carers to suspicious activity on monitored bank accounts. The second product is a B2B proposition that helps banks better protect their vulnerable customers by detecting if they are at risk of financial harm. 

With more older people now online and an increase of people living with dementia, the opportunities in the digital age continue to bring new possibilities for the vulnerable to fall victim to financial harm. Furthermore, reforms to private pensions mean fraudsters are provided with further opportunity to potentially draw all their victim’s pensions in cash. 

The Company is now working with a number of banks, offering their technology as a SaaS solution to provide clients with additional financial security.

Kalgera Limited Website
Milestones to Date
2018

Deepbridge initially invested £130k via the Deepbridge Life Sciences SEIS.

2019

Secured £100k Innovate UK grant.

Press coverage in The Times “Start-Ups put their faith in tech for good”.

2020

Contract signed with first major bank. Finalist in the TechRound100.

Risks and Important Information

This page is a financial promotion for the purposes of Section 21 of the Financial Services and Markets Act 2000. The content of the page has been approved by Deepbridge Capital LLP. The Company may not gain the commercial traction that is forecast, it could experience development problems and may not be able to achieve its objectives. Please note that these risks are by no means exhaustive and there may be other risks which could have a material adverse impact on the Company’s financial performance. The content should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors could lose the total value of their investment. Investments in small unquoted companies carry a high- level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Tax treatment depends on the individual circumstances of each investor and may be subject to change in future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status. Deepbridge does not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.